Changes in CD4+CD25+Foxp3+ Regulatory T Cells in Relation to Aging and Lung Tumor Incidence

Anisimov, 2009, Carcinogenesis and aging 20 years after: escaping horizon, Mech Aging Dev, 130, 105, 10.1016/j.mad.2008.02.004 Franceschi, 2001, Cancer epidemiology in the elderly, Crit Rev Oncol Hematol, 39, 219, 10.1016/S1040-8428(01)00102-0 Bürkle, 2007, Pathophysiology of ageing, longevity and age related diseases, Immun Ageing, 4, 1, 10.1186/1742-4933-4-4 Pawelec, 2008, Are cancer and ageing different sides of the same coin? Conference on cancer and ageing, EMBO Rep, 9, 234, 10.1038/embor.2008.12 Campisi, 2009, Aging and cancer cell biology, Aging Cell, 8, 221, 10.1111/j.1474-9726.2009.00475.x Irmiger-Finger, 2007, Science of cancer and aging, J Clin Oncol, 25, 1844, 10.1200/JCO.2007.10.8928 Bhardwaj, 2007, Harnessing the immune system to treat cancer, J Clin Invest, 117, 1130, 10.1172/JCI32136 Piccirillo, 2001, Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells, J Immunol, 167, 1137, 10.4049/jimmunol.167.3.1137 Suri-Payer, 1998, CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells, J Immunol, 160, 1212, 10.4049/jimmunol.160.3.1212 Shevach, 2001, Control of T-cell activation by CD4+CD25+ suppressor T cells, Immunol Rev, 182, 58, 10.1034/j.1600-065X.2001.1820104.x Zou, 2006, Regulatory T cells, tumor immunity and immunotherapy, Nat Rev Immunol, 6, 295, 10.1038/nri1806 Gregg, 2005, The number of human peripheral blood CD4+CD25high regulatory T cells increases with age, Clin Exp Immunol, 140, 540, 10.1111/j.1365-2249.2005.02798.x Parkin, 2002, Global cancer statistics, CA Cancer J Clin, 2005, 74 Batura-Gabryel, 2005, Lung cancer in the elderly – increasing epidemiological problem of 21st century, Rocz Akad Med Bialymst, 50, 152 Provinciali, 2005, Immunoprevention and immunotherapy of cancer in aging, Cancer Immunol Immunother, 54, 93, 10.1007/s00262-004-0539-3 Linton, 2001, T cell senescence, Front Biosci, 6, 248, 10.2741/A610 Lustgarten, 2004, Aged mice develop protective antitumor immune responses with appropriate costimulation, J Immunol, 173, 4510, 10.4049/jimmunol.173.7.4510 Wang, 2010, Altered CD28 and CD95 mRNA expression in peripheral blood mononuclear cells from elderly patients with primary non-small cell lung cancer, Chin Med J, 123, 51 Yagi, 2004, Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells, Int Immunol, 16, 1643, 10.1093/intimm/dxh165 Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057, 10.1126/science.1079490 Sakaguchi, 2004, Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses, Annu Rev Immunol, 22, 531, 10.1146/annurev.immunol.21.120601.141122 Huang, 2004, Role of LAG-3 in regulatory T cells, Immunity, 21, 503, 10.1016/j.immuni.2004.08.010 Shimizu, 2002, Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance, Nat Immunol, 3, 135, 10.1038/ni759 Shevach, 2006, The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity?, Nat Rev Immunol, 6, 613, 10.1038/nri1867 Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat Immunol, 4, 330, 10.1038/ni904 Khattri, 2003, An essential role for scurfin in CD4+CD25+ T regulatory cells, Nat Immunol, 4, 337, 10.1038/ni909 Muller, 2006, Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors, Nat Rev Cancer, 6, 613, 10.1038/nrc1929 Sharma, 2006, High accumulation of T regulatory cells prevents the activation of immune responses in aged animals, J Immunol, 177, 8348, 10.4049/jimmunol.177.12.8348 Zhao, 2007, Changes of CD4+CD25+Foxp3+ regulatory T cells in aged BALB/c mice, J Leukocyte Biol, 81, 1386, 10.1189/jlb.0506364 Beyer, 2005, Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine, Blood, 106, 2018, 10.1182/blood-2005-02-0642 Putheti, 2004, Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs, J Clin Immunol, 24, 155, 10.1023/B:JOCI.0000019780.93817.82 Moo-Young, 2009, Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer, J Immunother, 32, 12, 10.1097/CJI.0b013e318189f13c Chen, 2003, Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152 Pioli, 1998, Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice, Immunology, 94, 380, 10.1046/j.1365-2567.1998.00523.x Wan, 2006, The roles for cytokines in the generation and maintenance of regulatory T cells, Immunol Rev, 212, 114, 10.1111/j.0105-2896.2006.00407.x Fisson, 2003, Continuous activation of autoreactive CD4+CD25+ regulatory T cells in the steady state, J Exp Med, 198, 737, 10.1084/jem.20030686